MEETING CANCELLED: Immunity in Early Life: From the Maternal to the Microbial Environment
joint with MEETING CANCELLED: Maternal-Fetal Crosstalk
Organizer(s): Chris Wilson, Tobias Kollmann and Claire-Anne SiegristDate: June 07 - 11, 2020
Location: Keystone Resort, Keystone, CO, USA
For important information on the coronavirus, please click here
The immune system is crucial for host defense from infection and malignancy. It impacts nearly all of host physiology and, when misdirected, causes allergic and autoimmune disease. Recently, it has become increasingly clear that early life is a key period during which host genetics, developmental programs, and the environment (from infection to vaccination to microbiome etc.) shape the immune system. This imprint is then carried forward through childhood into adult life. Yet, this early life period represents not only a window of vulnerability but of opportunity, where targeted interventions could provide lifelong benefits. This Keystone Symposium conference examines early life immunity, bringing together experts from a sundry range of disciplines. This diverse group will present a tapestry of extant knowledge and insights, provide a more comprehensive understanding of immune ontogeny, and illuminate areas of uncertainty where further study is most needed. Conference participants will leave with an understanding of the role of microbiome in early life immune ontogeny. In addition, discussion on the precise mechanistic role of early life immunity in health versus disease will be included in sessions. Finally, given that crucial events in immune ontogeny may be influenced by prenatal events, this conference will be held jointly with Maternal-Fetal Crosstalk, which emphasizes the strong overlap and interdependence of fetal and neonatal with maternal immunity. There will be joint sessions which will provide the unique opportunity to cross-fertilize pre- and postnatal immunity.
Meeting has been cancelled. Please call our office if you have questions at 970-262-1230 or 1-800-253-0685.
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1 R13 AI152254-01
Funding for this conference was made possible (in part) by 1 R13 AI152254-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.